API
< Back to all clusters
[BUSINESS] · United States · 4 sources

started · updated

Alcon receives FDA approval for BRYTLY eye drops

Alcon has announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY Redness Reliever Eye Drops. The over-the-counter product is designed to significantly reduce eye redness within one minute, providing results that can last up to 12 hours.

According to the company, BRYTLY lasts up to 50% longer than Lumify and contains no bleaches or dyes. Clinical studies indicated a low risk of redness rebound and tachyphylaxis when the product is used as directed. The approval expands Alcon’s consumer eyecare portfolio, targeting the intersection of beauty and wellness routines.

Entities

Alcon · BRYTLY · U.S. Food and Drug Administration